470 likes | 487 Views
This is a demo version of Williams & Marshall Strategy's report on the caprolactam market in North America. The report presents a strategic analysis of the caprolactam market in the region and a forecast for its development in the medium term. It provides a comprehensive overview of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. This is the most detailed and comprehensive report about the caprolactam market in North America currently available!
E N D
Demo version North America: Ammonium Sulphate Market. j Demo version of the report North America: Caprolactam Market January 2019 April 2018 GLOBAL MARKET INSIGHTS WILLIAMS&MARSHALL STRATEGY Market research Page 1of 47 www.wm-strategy.com Contact us: info@wm-strategy.com https://www.wm-strategy.com/
Demo version North America: Caprolactam Market. January 2019 Report overview Report overview This report presents a strategic analysis of the caprolactam market in North America and a forecast for its development in the medium term. It provides a comprehensive overview of the market, its dynamics, structure, characteristics, main players, growth and demand drivers, etc. This is the most detailed and comprehensive report about the caprolactam market in North America currently available! The purpose of the report is to describe the state of the caprolactam market in North America, to present actual and retrospective information about the volumes, dynamics, structure and characteristics of production, imports, exports and consumption and to build a forecast for the market in the next five years. In addition, the report presents an elaborate analysis of the main market participants, price fluctuations, growth and demand drivers of the market and all other factors, influencing its development. It also focuses on the overall installed production capacities in each country within the region along with the main producers on the market, the technologies each of them uses and the average utilization rates. This research report has been prepared using the unique WMStrategy’s methodology, including a blend of qualitative and quantitative data. The information comes from official sources and insights from market experts (representatives of the main market participants), gathered by semi-structured interviews. The report on the caprolactam market in North America includes: Analysis and forecast for the economy of North America; Analysis and forecast for development of the market volume (market size), value and dynamics; Market breakdown (by origin, by country, etc.); Volume and dynamics of all installed capacities for the production of caprolactam in North America and forecast for their development in the medium term; Breakdown of all installed capacities for the production of caprolactam in North America by their owner and operator companies and countries; Main technologies used for producing caprolactam in North America in the main plants of each of the domestic market players; Average annual utilization rates for the production of caprolactam in North America and forecast for their development in the medium term; Country information - breakdown by country for all major indicators, showing the exact volumes and values for each individual country, covered in the report; Volume, dynamics and analysis of domestic production (past, current and future); Page 2of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Analysis of price levels (wholesale, retail, distributors, etc.) and their dynamics (past, current and future); Volume, dynamics and analysis of imports (past, current and future); Volume, dynamics and analysis of exports (past, current and future); Volume, dynamics and analysis of consumption (past, current and future); Characteristics of the main market participants (manufacturers, distributors, wholesalers, retailers, importers, exporters, Governmental structures, etc.) and the competitive landscape; Profiles of the main companies, producing caprolactam in North America along with their overall production capacities; Value chain analysis and structure of price formation; Analysis of the factors, influencing the market development (market growth drivers, restraints, recent state programs, etc.); Analysis and forecast of the trends and levels of supply and demand on the market; Country opportunity analysis; Analysis of the major trade flows; Forecast for market development in the medium term (including three possible scenarios for development). Brief overview of the used methodology: Analysis of official statistical information; Semi structured interviews with market experts; Semi structured interviews with corporate clients of the market; Analysis of information, received from the main market participants; Analysis of secondary information from official sources; WMStrategy own methodology. The report contains information on the following products: Caprolactam, used for the further processing into: o Polyamide Fibers; o PAM Resins (6+66); o Others (Chips). The report covers the following countries: North America: Canada, Mexico, The USA. Page 3of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 The report covers the following companies, along with their installed production capacities: Advansix; BASF Corp.; Fibrant. This report will allow you to: Quickly and cost–effectively get a strategic analysis and gain competitive intelligence about the market; Track market data, including size, value, segmentation, forecasts, dynamics and structure – past, present and future; See the exact usage of caprolactam in North America by main applications/product groups in the last five years and a forecast for its development in the medium term; Evaluate the overall installed capacities used for the production of caprolactam in North America and their utilization rates in the last five years and a forecast for their development in the medium term; Strategically assess the competitive position of the main domestic producers, along with their overall installed capacities and production techniques; Get and compare information at both aggregate level (for the whole region) and for each individual country, covered in the report; Explore and identify new market opportunities in the countries and regions within the market; Track and identify key market trends, opportunities and threats and key drivers behind recent market changes; Strategically assess market growth potential, demand drivers and restraints on the market; Evaluate the key macroeconomic indicators to get insight into the general trends within the economy; See how the market performed in the past (over the last 5 years) and how it will perform in the future (in the next 5 years); Get acquainted with the leading companies on the market; Evaluate how diversified the market is in terms of competitive intensity, fragmentation and environment and understand competitive threats; Empower your marketing, branding, strategy and market development, consumption and supply functions with useful market insights; Build your investment strategy by assessing market attractiveness or company Page 4of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 attractiveness; Build your own market entry or market expansion strategy or evaluate your current strategy; Add value to pitches and presentations by using official and accurate data and calculations. We have all the data for this report already available and the report is 75% ready and is in completion stage. With each License, you will get an Excel sheet with all the quantitative information in up to 1 working day after your purchase, which will allow you to start working with the data immediately! The final version of the research report will be presented up to 5 working days after your order. The report will be updated as of the current month of purchase. Feel free to contact us for more information! This is the most comprehensive report covering the caprolactam market in North America currently available! We also offer similar reports, covering every global country, region and the world as an overall and offer special terms for bundle purchases. So, if you are interested in the caprolactam market in North America, this research report will provide you with a strategic analysis of the market, its recent and future development. In addition, the report will save you time and money while presenting you all the necessary information, empowering you to make informed decisions and move your business forward! Page 5of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Research methodology Research methodology The report on the North American caprolactam market uses the unique WMStrategy’s research methodology that combines quantitative and qualitative analysis. 1. Analysis of official statistical information This report includes analysis of official statistical information from different public and private sources. The information is used for the interpretation and analysis of data on the volume and dynamics of different quantitative indicators. In the same way, the information is used as basis for building forecasts for the dynamics of the quantitative indicators for the next few years. The exact list of used sources of official information is available in the full report! 2. Analysis of information, received from the main market participants The collection and analysis of information, received from the main market participants is done mainly to understand their competitive positions on the market, to define and assess how different pricing and promotional strategies are utilized on the market and what competitive advantage each of them gives.This information is also used to analyze the assortment and brand presence on the market. The information, received from the main market participants include company presentations, annual reports, price lists, promotional materials, proposals, etc. 3. Analysis of secondary information from official sources The analysis of secondary information from official sources is used to make the picture of the market complete and full. The data is also used to verify the quantitative analysis and to enrich the qualitative one. Such information include data from industry portals and publications, trade associations, media agencies, articles and reviews, marketing agencies, commercial databases, WMStrategy own research studies. 4. Semi structured interviews with market experts Collection and analysis of qualitative information is used to explain different trends, growth drivers, volatility, threats and opportunities of the market. The collection of qualitative information is done through semi structured interviews with market experts. As market experts are considered representatives of the main market participants – manufacturers, distributors, wholesalers, retailers, importers, exporters, unions, professional associations Page 6of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 and special publications, whose work is directly related to this particular market on a daily basis. The format of the semi structured interviews allows us not only tocover the main questions we need to ask in order to understand the logic behind the market,but also to get new insights and to allow new ideas and factors to come into the picture.During the semi structured interviews, the market experts are asked about their views on thefuture of the market, which are taken into consideration while preparing our forecasts fordevelopment. The exact list of interviewed experts is available in the full report or upon request! 5. Semi structured interviews with corporate clients of the market Another way of looking into the specific market is through the point of view of the corporate clients. In this phase of the research, we are using semi structured interviews to understand the perspective of the high-volume clients on the market. This allows for unmatched wide and deep industry understanding. 6. WMStrategy own methodology The own methodology of WMStrategy can be found in every step of preparing our research studies from the methodology through the processes of collecting and analyzing information to drawing conclusions from it. Page 7of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Table of contents Table of contents 1. Introduction 1.1. Report description 1.2. Research methodology 2. Executive summary 3. Characteristics of caprolactam 4. Characteristics and analysis of raw materials base 5. State of the economy of North America 5.1. Characteristics of the economy of North America in 2013-2017 5.2. Forecast for the development of the economy of North America for 2018-2020 6. Overview and analysis of the caprolactam market in North America 6.1. Volume, value and dynamics of the caprolactam market in North America in 2013- 2017 6.2. Structure of the caprolactam market in North America in 2013-2017: production, imports, exports, consumption 6.3. Structure of the caprolactam market in North America in 2013-2017 by origin 6.4. Structure of the caprolactam market in North Americain 2013-2017 by country 6.5. Structure of the caprolactam market in North America in 2013-2017 by application/main product groups and forecast for its development in the medium term 6.6. Key recent trends on the caprolactam market in North America 6.7. Competitive landscape of the market 6.8. Country opportunity analysis 6.9. Key drivers and restraints for the market development in the medium term 7. Overview and analysis of the domestic production of caprolactam in North America 7.1. Volume, distribution and dynamics of the installed capacities for the production of caprolactam in North America broken down by country in the last 5 years and forecast for their development in the medium term 7.2. Volume and dynamics of the average annual utilization rates used for the production of caprolactam in North America in the last 5 years and forecast for their development in the medium term 7.3. Volume, value and dynamics of the domestic production of caprolactam in North America in 2013-2017 and forecast for 2018-2023 7.4. Structure of the North American production of caprolactam in 2013-2017 by countries Page 8of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 7.5. Characteristics of the main producers of caprolactam in North America along with their exact installed capacities and used production techniques in the last 5 years and forecast for their development in the medium term 8. Characteristics and analysis of the prices of caprolactam in North America 8.1. Value chain analysis 8.2. Structure of price formation 8.3. Characteristics of the producer prices of caprolactam in North America in 2013- 2017 8.4. Characteristics of other prices of caprolactam 9. Trade balance of the foreign trade operations of caprolactam in North America 9.1. Trade balance of the foreign trade operations of caprolactam in North America in 2013-2017 10. Overview and analysis of the imports of caprolactam to the North American market 10.1. Volume, value and dynamics of the imports of caprolactam to North America in 2013-2017 10.2. Major trade inflows of caprolactam imports to North America in 2013-2017 10.3. Structure of the imports of caprolactam in 2013-2017 by importing countries 10.4. Average prices of the caprolactam, imported to North America in 2013-2017 11. Overview and analysis of the North American exports of caprolactam 11.1. Volume, value and dynamics of the North American exports of caprolactam in 2013-2017 11.2. Major trade outflows of caprolactam exports from North America in 2013-2017 11.3. Structure of the North American exports of caprolactam in 2013-2017 by exporting countries 11.4. Average prices of the North American exports of caprolactam in 2013-2017 12. Characteristics of the consumption of caprolactam in North America 12.1. Volume, value and dynamics of the consumption of caprolactam in North America in 2013-2017 12.2. Structure of the consumption of caprolactam in North America in 2013-2017 (by origin, by channel, by country) 12.3. Volume, value and dynamics of the per capita consumption of caprolactam in North America in 2013-2017 12.4. Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017 and forecast for its development in the medium term 13. Forecast for development of the caprolactam market in North America in 2018- 2023 13.1. Factors, influencing the development of the caprolactam market in North America in the medium term Page 9of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 13.2. Forecast for market development in the medium term under three possible scenarios About WMStrategy List of tables • Key indicators on the caprolactam market in North America in 2013-2017 • Key indicators of the economy of North America in 2013-2017 • Forecast for the economy of North America in 2018-2020 • Volume and dynamics of the caprolactam market in North America in 2013-2017 • Value and dynamics of the caprolactam market in North America in 2013-2017 • Structure of the caprolactam market in North America in 2013-2017, in volume terms • Structure of the caprolactam market in North America in 2013-2017, in value terms • Structure of the caprolactam market in North America by origin in 2013-2017, in volume terms • Structure of the caprolactam market in North America by origin in 2013-2017, in value terms • Structure of the caprolactam market in North America by country in 2013-2017, in volume terms • Structure of the caprolactam market in North America by country in 2013-2017, in value terms • Structure of the caprolactam market in North America by application/main product groups in 2013-2017, in volume terms • Forecast for the structure of the caprolactam market in North America by application/main product groups in 2018-2023, in volume terms • Country opportunity analysis • Volume and dynamics of the installed capacities for the production of caprolactam in North America in 2013-2017 by main countries • Volume and dynamics of the installed capacities for the production of caprolactam in North America in 2013-2017 by main companies • Forecast for the installed capacities for the production of caprolactam by main countries in North America in 2018-2023 • Forecast for the installed capacities for the production of caprolactam by main companies in North America in 2018-2023 • Volume and dynamics of the average annual utilization rates used for the production of caprolactam in North America in 2013-2017 Page 10of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 • Forecast for the average annual utilization rates used for the production of caprolactam in North America in 2018-2023 • Volume and dynamics of the domestic production of caprolactam in North America in 2013- 2017 • Value and dynamics of the domestic production of caprolactam in North America in 2013- 2017 • Structure of the domestic production of caprolactam in North America by producing countries in 2013-2017, in volume terms • Structure of the domestic production of caprolactam in North America by producing countries in 2013-2017, in value terms • Forecast for the production of caprolactam in North America in 2018-2023 • Structure of the domestic producers of caprolactam by overall installed production capacities in North America in 2013-2017 and forecast for their development in 2018-2023 • Value chain analysis of the caprolactam market in North America • Cost breakdown of the price formation of caprolactam in North America, in % • Volume and dynamics of the average producer prices of caprolactam in North America in 2013-2017 • Volume and dynamics of the average producer prices of caprolactam in North America by producing countries in 2013-2017 • Volume and dynamics of other prices of caprolactam in North America (wholesale, distributor, retail, etc.) in 2013-2017 • Trade balance of caprolactam foreign trade in North America in 2013-2017, in volume terms • Trade balance of caprolactam foreign trade in North America in 2013-2017, in value terms • Trade balance of caprolactam foreign trade in North America by trading countries in 2013- 2017, in volume terms • Trade balance of caprolactam foreign trade in North America by trading countries in 2013- 2017, in value terms • Volume and dynamics of the imports of caprolactam to North America in 2013-2017 • Value and dynamics of the imports of caprolactam to North America in 2013-2017 • Main countries, exporting caprolactam to North America in 2013-2017, in volume terms • Main countries, exporting caprolactam to North America in 2013-2017, in value terms • Structure of the imports of caprolactam to North America by importing countries in 2013- 2017, in volume terms • Structure of the imports of caprolactam to North America by importing countries in 2013- 2017, in value terms • Average prices of the caprolactam, imported to North America in 2013-2017 • Average prices of the caprolactam, imported to North America in 2013-2017 by importing countries • Volume and dynamics of the North American exports of caprolactam in 2013-2017 Page 11of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 • Value and dynamics of the North American exports of caprolactam in 2013-2017 • Recipient countries of the North American exports of caprolactam in 2013-2017, in volume terms • Recipient countries of the North American exports of caprolactam in 2013-2017, in value terms • Structure of the North American exports of caprolactam by exporting countries in 2013- 2017, in volume terms • Structure of the North American exports of caprolactam by exporting countries in 2013- 2017, in value terms • Average prices of the North American exports of caprolactam in 2013-2017 • Average prices of the North American exports of caprolactam in 2013-2017 by exporting countries • Volume and dynamics of the consumption of caprolactam in North America in 2013-2017 • Value and dynamics of the consumption of caprolactam in North America in 2013-2017 • Structure of the consumption of caprolactam in North America in 2013-2017, in volume terms • Structure of the consumption of caprolactam in North America in 2013-2017, in value terms • Structure of the consumption of caprolactam in North America by consuming countries in 2013-2017 • Volume and dynamics of the per capita consumption of caprolactam in North America in 2013-2017 • Value and dynamics of the per capita consumption of caprolactam in North America in 2013- 2017 • Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017, in volume terms • Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017, in value terms • Forecast for the total demand for caprolactam in North America in 2018-2023 (under the framework of the base scenario), in volume and value terms • Forecast for the total demand for caprolactam in North America in 2018-2023 (under the framework of the pessimistic scenario), in volume and value terms • Forecast for the total demand for caprolactam in North America in 2018-2023 (under the framework of the optimistic scenario), in volume and value terms Page 12of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 List of figures • Volume and dynamics of the caprolactam market in North America in 2013-2017 • Value and dynamics of the caprolactam market in North America in 2013-2017 • Structure of the caprolactam market in North America in 2013-2017, in volume terms • Structure of the caprolactam market in North America in 2013-2017, in value terms • Structure of the caprolactam market in North America by origin in volume terms in 2013- 2017 • Structure of the caprolactam market in North America by origin in value terms in 2013-2017 • Structure of the caprolactam market in North America by country in 2013-2017, in volume terms • Structure of the caprolactam market in North America by country in 2013-2017, in value terms • Structure of the caprolactam market in North America by application/main product groups in 2013-2017, in volume terms • Forecast for the structure of the caprolactam market in North America by application/main product groups in 2018-2023, in volume terms • Volume and dynamics of the installed capacities for the production of caprolactam in North America in 2013-2017 by main countries • Volume and dynamics of the installed capacities for the production of caprolactam in North America in 2013-2017 by main companies • Forecast for the installed capacities for the production of caprolactam by main countries in North America in 2018-2023 • Forecast for the installed capacities for the production of caprolactam by main companies in North America in 2018-2023 • Volume and dynamics of the average annual utilization rates used for the production of caprolactam in North America in 2013-2017 • Forecast for the average annual utilization rates used for the production of caprolactam in North America in 2018-2023 • Volume and dynamics of the domestic production of caprolactam in North America in 2013- 2017 • Value and dynamics of the domestic production of caprolactam in North America in 2013- 2017 • Structure of the domestic production of caprolactam in North America by producing countries in 2013-2017, in volume terms • Structure of the domestic production of caprolactam in North America by producing countries in 2013-2017, in value terms • Forecast for the production of caprolactam in North America in 2018-2023 Page 13of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 • Structure of the domestic producers of caprolactam by overall installed production capacities in North America in 2013-2017 and forecast for their development in 2018-2023 • Value chain analysis of the caprolactam market in North America • Structure of the caprolactam price formation in North America, in % • Volume and dynamics of the average producer prices of caprolactam in North America in 2013-2017 • Deviation of the average producer prices of caprolactam in North America in 2013-2017 by producing countries • Volume and dynamics of other prices of caprolactam in North America (wholesale, distributor, retail, etc.) in 2013-2017 • Trade balance of caprolactam foreign trade in North America in 2013-2017, in volume terms • Trade balance of caprolactam foreign trade in North America in 2013-2017, in value terms • Trade balance of caprolactam foreign trade in North America by trading countries in 2013- 2017, in volume terms • Trade balance of caprolactam foreign trade in North America by trading countries in 2013- 2017, in value terms • Volume and dynamics of the imports of caprolactam to North America in 2013-2017 • Value and dynamics of the imports of caprolactam to North America in 2013-2017 • Main countries, exporting caprolactam to North America in 2013-2017, in volume terms • Main countries, exporting caprolactam to North America in 2013-2017, in value terms • Structure of the imports of caprolactam to North America by importing countries in 2013- 2017, in volume terms • Structure of the imports of caprolactam to North America by importing countries in 2013- 2017, in value terms • Average prices of the caprolactam, imported to North America in 2013-2017 • Average prices of the caprolactam, imported to North America in 2013-2017 by importing countries • Volume and dynamics of the North American exports of caprolactam in 2013-2017 • Value and dynamics of the North American exports of caprolactam in 2013-2017 • Recipient countries of the North American exports of caprolactam in 2013-2017, in volume terms • Recipient countries of the North American exports of caprolactam in 2013-2017, in value terms • Structure of the North American exports of caprolactam by exporting countries in 2013- 2017, in volume terms • Structure of the North American exports of caprolactam by exporting countries in 2013- 2017, in value terms • Average prices of the North American exports of caprolactam in 2013-2017 Page 14of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 • Average prices of the North American exports of caprolactam in 2013-2017 by exporting countries • Volume and dynamics of the consumption of caprolactam in North America in 2013-2017 • Value and dynamics of the consumption of caprolactam in North America in 2013-2017 • Structure of the consumption of caprolactam in North America in 2013-2017, in volume terms • Structure of the consumption of caprolactam in North America in 2013-2017, in value terms • Structure of the consumption of caprolactam in North America by consuming countries in 2013-2017 • Volume and dynamics of the per capita consumption of caprolactam in North America in 2013-2017 • Value and dynamics of the per capita consumption of caprolactam in North America in 2013- 2017 • Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017, in volume terms • Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017, in value terms • Forecast for the total demand for caprolactam in North America in 2018-2023 (under the framework of the base scenario), in volume and value terms • Forecast for the total demand for caprolactam in North America in 2018-2023 (under the framework of the pessimistic scenario), in volume and value terms • Forecast for the total demand for caprolactam in North America in 2018-2023 (under the framework of the optimistic scenario), in volume and value terms Page 15of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 2. 2. Executive summary Executive summary The North American caprolactam market showed … dynamics in volume terms in the period 2013-2017. In 2013, it was equal to 526 thousand tons. In the next four years, it changed on an annual basis at rates of X%, X%, X% and X%, respectively. So, in 2017, the market reached X thousand tons. This was an overall growth of about X% for the past five years. In the medium term, experts believe that the market will continue its growth at rates of about X%-X% per year. In value terms, the caprolactam market in North America showed similar dynamics to the same indicator in volume terms. In 2013, it was equal to X million USD... … Table 1 Key indicators on the North American caprolactam market in 2013-2017 Indicators 2013 2014 2015 2016 2017 Market volume and value in North America in 000’s tons 526 … … … … in 000's of USD … … … … … Volume and value of production in North America in 000’s tons … … … … … in 000's of USD … … … … … Volume and value of imports to North America in 000’s tons … 24 … … … in 000's of USD … … … … … Volume and value of the North American exports in 000’s tons … … … … … in 000's of USD … … … … … Share of domestically produced goods on the market, in physical terms Share of foreign products on the market, in physical terms …% …% …% …% …% …% …% …% …% …% Average prices on the domestic market … Average producer prices, in USD/ton Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis … … … … (WMStrategy) Page 16of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 6. 6. Overview and analysis Overview and analysis of the of the caprolactam caprolactam market market in in North North America America 6.1. 6.1. Volume, value and dynamics of the Volume, value and dynamics of the caprolactam 2017 2017 caprolactam market in market in North America North America in in 2013 2013- - The North American caprolactam market in 2013 was equal to about 526 thousand tons. In the next few years, it ... Table 2 Volume and dynamics of the caprolactam market in North America in 2013-2017, in thousands of tons and in % Year Market volume, in 000’s tons 2013 526 2014 … 2015 … 2016 … 2017 … Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Dynamics, in % 100% X% X% X% X% (WMStrategy) Volume and dynamics of the North American caprolactam market in 2013- 2017 X 250 115% X X X X 200 110% X% X% 150 105% 100 X% X% 100% 50 100% 0 95% 2013 2014 2015 2016 2017 Market volume, in 000's of tons Dynamics, in % Fig. 1 Volume and dynamics of the caprolactam market in North America in 2013- 2017, in thousands of tons and in %1 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 1Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 17of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 … 6.3. During the whole analyzed period, the market was dominated by … products in both volume and value terms. In physical ones, the share of products of domestic origin was in the range of X%-X% of the total market. In value terms, their share was in the range of X%-X%. In 2013, the domestically produced products accounted for X% of the market in physical and X% in value terms. In the next few years, their share … … 6.3. Structure of the Structure of the caprolactam caprolactam market in market in North America North America by origin by origin Table 3 Structure of the caprolactam market in North America by origin in 2013- 2017, in thousands of tons Year Market volume, in 000’s tons products, in 000’s tons 2013 526 Domestically produced Foreign products, in 000’s tons … … 2014 … … … 2015 … … … 2016 … … … 2017 … … … Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) Page 18of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Structure of the North American caprolactam market by origin in 2013- 2017 in volume terms, in % 90.00% X% X% X% X% X% 80.00% 70.00% 60.00% 50.00% 40.00% X% 30.00% X% X% X% X% 20.00% 10.00% 0.00% 2013 2014 2015 2016 2017 Domestically produced products, in 000's of tons Foreign products, in 000's of tons Fig. 2 Structure of the caprolactam market in North America by origin in 2013- 2017 in volume terms, in %2 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 6.4. 6.4. The countries with the largest caprolactam markets in volume terms in North America in 2017 were …, …, …, … and …. In total, they accounted for …% of the market in physical terms. … was the clear leader, as it alone accounted for …% of the market. The highest growing markets in North America in the last five years were …, … and …, which grew at CAGR of …%, …% and …%, respectively… … Structure of the Structure of the caprolactam caprolactam market in market in North America North America by countries in by countries in 2013 2013- -2017 2017 2Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 19of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Table 4 Structure of the caprolactam market in North America by countries in 2013-2017, in thousands of tons and in % Market volume in 2013, in 000’s tons tons tons Canada X X Market volume in 2014, in 000’s Market volume in 2015, in 000’s Market volume in 2016, in 000’s tons X Market volume in 2017, in 000’s tons X Country share in 2017, in % CAGR 2013- 2017 Country X X% 4.26 % X% X% 3.05% Mexico X X X X X X% The USA Total X X X X X X X X X X% X% 526 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) Structure of the North American caprolactam market by countries in 2017 in volume terms, in % Country A X% Country B X% Country C X% Country D Country E X% X% X% Country F X% X% Country G Other countries Fig. 3 Structure of the caprolactam market in North America in volume terms in 2017 by countries, in %3 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 3Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 20of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 6.5. 6.5. Structure of the Structure of the caprolactam application/main product groups and forecast for its development in the medium application/main product groups and forecast for its development in the medium term term caprolactam market in market in North America North America in 2013 in 2013- -2017 by 2017 by … Throughout the whole analyzed period, the usage had a relatively homogeneous structure. Most of the caprolactam regionally was used in the production of …, which in 2017 accounted for a share of about …% of the total in volume terms (…% in 2017). It was followed by use for the manufacture of … (with a share of …% in 2017), … and other usages (with shares of …% and …% in 2017, respectively). … Table 5 Volume and dynamics of the North American caprolactam market by usage in 2013-2017, in thousands of tons and in % Market volume in 2013, in 000's of tons tons tons Polyamide Fibers Market volume in 2014, in 000's of Market volume in 2015, in 000's of Market volume in 2016, in 000's of tons Market volume in 2017, in 000's of tons CAGR 2013- 2017 Share in 2017, in % Main usage … … … … … 0.91% X% Product B … … … … … X% X% Others (Chips) … … … … … X% 15.24% Total 526 … … … … X% 100% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) … In the medium term, the caprolactam consumption in the region is expected to grow the most in the production of …, which is expected to happen at a CAGR of …% per annum. It will be followed by the caprolactam usage for production of …, …, and …, which are forecast to grow at CAGR of …%, …%,and …% per year, respectively. The overall market volume is forecast to grow CAGR of …% per year to reach 681 thousand tons in 2023. Page 21of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Table 6 Forecast for the expected structure of the caprolactam market in North America by usage in 2018F-2023F, in volume terms Market volume in 2018F, in 000's of tons of tons of tons of tons Polyamide Fibers Product B … … … Others (Chips) Total … … … Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Market volume in 2019F, in 000's Market volume in 2020F, in 000's Market volume in 2021F, in 000's Market volume in 2022F, in 000's of tons Market volume in 2023F, in 000's of tons CAGR 2018F- 2023F Share in 2023F, in % Main usage … … … … … … -1.38% X% … … … X% X% … … … … … … X% 14.68% … … 681 X% 100% (WMStrategy) … 6.6. … 6.6. Key recent trends on the Key recent trends on the caprolactam caprolactam market in market in North America North America During the last several years, the development of the automobile industry is one of the major factors, driving the caprolactam market. This is due to the variety of applications of nylon 6 in different automotive parts such as door handles, air bag containers, radiator grilles, relay boxes, air intake manifold and engine covers, among others. Furthermore, automakers are focusing on light weighting of vehicles in order to improve fuel efficiency and performance. Therefore, metallic parts of automobile are being rapidly replaced by nylon 6 due to high temperature and chemical resistance. In addition, innovation in the field of electronics along with increasing consumption of smart phones, tablets, laptops and TVs has resulted in driving demand for engineering plastics, subsequently driving the growth of the caprolactam market. The growing demand for convenience food is also a major contributor for the demand growth for specialty films for packing. Since nylon 6 is a key constituent in specialty films, the latter is driving the caprolactam market. … 6.7. Competitive landscape of the market Competitive landscape of the market … The main players on the market are large multinational companies, which have the resources to compete for large contracts. However, most of them are quite diversified in terms of product and geographical operations and therefore less reliant on this particular market alone. The caprolactam market is characterized by relatively low product differentiation, although products are less commoditized than most base chemicals. The barriers to market entry include capital requirements for establishing manufacturing facilities, and increasingly stringent regulation, which all serve to increase rivalry… 6.7. Page 22of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 7 7. . Overview and analysis of the domestic production of Overview and analysis of the domestic production of caprolactam caprolactam in in North America North America 7.1. 7.1. Volume, distribution and dynamics of the installed capacities for the production o Volume, distribution and dynamics of the installed capacities for the production of f caprolactam caprolactam in in North America North America broken down by country in the last 5 years and broken down by country in the last 5 years and forecast for their development in the medium term forecast for their development in the medium term Caprolactam is manufactured in several developed countries in North America. … As of 2017, the largest capacity base was in … and accounted for a share of X% of all installed North American capacities. They were followed by … with shares of X% and X% of all installed North American capacities, respectively. As for dynamics, … registered the highest dynamics, increasing at CAGR of X% and X% per annum, respectively. … Table 7 Distribution of caprolactam production capacities in North America, broken down by countries in 2013-2017, in thousands of tons and in % Prod. capacity in 2013, in 000's of tons tons tons Canada … … … Prod. capacity in 2014, in 000's of Prod. capacity in 2015, in 000's of Prod. capacity in 2016, in 000's of tons … Prod. capacity in 2017, in 000's of tons … CAGR 2013- 2017 Share in 2017, in % Country X% X% Mexico 85 … … … … X% X% The USA … … … … … X% 88.23% Total X X X X X X% 100% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) Page 23of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 7.2. 7.2. Volume and dynamics of the average annual utilization rates used for the Volume and dynamics of the average annual utilization rates used for the production of production of caprolactam caprolactam in in North North America America in the last 5 years and forecast for their development in the medium term development in the medium term in the last 5 years and forecast for their … Table 8 Caprolactam average annual capacity utilization rates in North America, broken down by countries in 2013-2017, in % Average annual capacity util. rate in 2013, in % in % in % Canada X% X% X% Mexico X% X% X% The USA X% X% X% Total X% X% X% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Average annual capacity util. rate in 2014, Average annual capacity util. rate in 2015, Average annual capacity util. rate in 2016, in % X% X% X% X% Average annual capacity util. rate in 2017, in % X% X% X% X% CAGR 2013- 2017 Country X% X% X% X% (WMStrategy) 7.3. 7.3. Volume, value and dynamics of the domestic production of Volume, value and dynamics of the domestic production of caprolactam America America in in 2013 2013- -2017 2017 and forecast for 2018 and forecast for 2018- -2023 caprolactam in in North North 2023 As an overall, the North American production of caprolactam in volume terms showed mixed dynamics in the period 2013-2017. In 2013, in North America were produced 765 thousand tons of caprolactam. In the next year, the production increased by …%, which was followed by two years of decline. It happened at rates of …% and …%, respectively. In 2017, the production volume … by …% and reached … tons, which was its … value for the period.This was an overall … of …% for the last five years. Experts forecast that in the next few years, the North American production will … at … rates of …% per year. … Page 24of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Value and dynamics of the North American production of caprolactam in 2013-2017 600 112% X 110% X 500 X 108% X X% X X% 400 106% X% X% 104% 300 102% 200 100% 100% 98% 100 96% 0 94% 2013 2014 2015 2016 2017 Production value, in 000's of USD Dynamics, in % Fig. 4 Value and dynamics of the domestic production of caprolactam in North America in 2013-2017, in thousands of USD and in %4 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) … 4Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 25of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 7.4. 7.4. Structure of the Structure of the North American North American production of production of caprolactam caprolactam in 2013 in 2013- -2017 by 2017 by countries countries The countries that produced the most caprolactam in volume terms in North America in 2017 were …, …, …, … and …. In total, they accounted for …% of the regional production in physical terms in the same year. … was the clear leader, as it alone accounted for …% of the production in North America. The highest growing production in the last five years was recorded in …, … and …, which grew at CAGR of …%, …% and …% per year, respectively… … Table 9 Volume and dynamics of the caprolactam production in North America, broken down by countries in 2013-2017, in thousands of tons and in % Prod. in 2013, in 000’s of tons tons tons Prod. in 2014, in 000’s of Prod. in 2015, in 000’s of Prod. in 2016, in 000’s of tons Prod. in 2017, in 000’s of tons Country share in 2017, in % CAGR 2013- 2017 Country Canada … … … … … …% …% Mexico … … … … … …% 11.82% The USA 695 … … … … …% …% Total … … … … … …% 100% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) … Page 26of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 7.5. 7.5. Characteristics of the main producers of Characteristics of the main producers of caprolactam their exact installed capacities and used production techniques in the last 5 years their exact installed capacities and used production techniques in the last 5 years and forecast for their development in the medium term and forecast for their development in the medium term caprolactam in in North America North America along with along with At the moment, in North America there are … caprolactam manufacturers. The report includes some of the leading manufacturers, ranked in terms of their overall installed capacities for the production of caprolactam as of 2017. … 7.5.1. BASF Corp. BASF Corporation operates as a North American subsidiary of the world's largest chemicals company, BASF SE. Like its German parent, it manufactures ingredients for several markets: chemicals (inorganics, petrochemicals, and intermediate products), performance products (paper, personal care, and pharma chemicals), functional solutions (catalysts, industrial coatings, and construction chemicals), and agricultural (fungicides, herbicides, and insecticides). In 2013 it opened a 33 million USD facility expansion in Research Triangle Park, North Carolina. BASF Corporation is responsible for about a fifth of BASF SE's total sales. … In the fiscal 2017, the company reported revenues, amounting to … USD, which was a … of …%, compared to the previous year. As far as net income is concerned, BASF Corp. recorded … USD, compared to … USD in the fiscal 2016. … Table 10 Installed capacities for the production of caprolactam by BASF Corp., broken down by countries in North America in 2013-2017, in thousands of tons and in % Prod. capacity in 2013, in 000's of tons of tons of tons Country A X X X Prod. capacity in 2014, in 000's Prod. capacity in 2015, in 000's Prod. capacity in 2016, in 000's of tons X Prod. capacity in 2017, in 000's of tons X Share in 2017, in % CAGR 2013- 2017 Country X% X% Country B X X X X X X% X% Total X X X X X X% X% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) Page 27of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 8 8. . Characteristics and analysis of the prices of Characteristics and analysis of the prices of caprolactam caprolactam in in North North America America … 8.3. 8.3. Characteristics of the producer prices of Characteristics of the producer prices of caprolactam … caprolactam in in North America North America in in 2013 2013- -2017 2017 The average annual prices of caprolactam in North America in the period 2013-2017 showed … dynamics. In 2013, one ton of caprolactam, purchased directly from the producer cost about … USD in North America. In the next four years, the indicator recorded steady … with only one exception in 2014, when it … by …%. Its … rates in the other years were …%, …% and …%, respectively. So, in 2017, the average producer price reached … USD per ton, which was an overall … of …% for the period. Experts expect that the average producer prices will … in the next five years at … rates of …% per annum. Table 11 Volume and dynamics of the average producer prices of caprolactam in North America in 2013-2017, in USD per ton and in % Year Average producer price, in USD/ton 2013 … 2014 … 2015 … 2016 … 2017 … Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Dynamics, in % 100% …% …% …% …% (WMStrategy) … Page 28of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 10 10. . Overview and analysis of the imports of Overview and analysis of the imports of caprolactam caprolactam to the to the North American North American market market … … 10 10. .2 2. Major trade inflows of . Major trade inflows of caprolactam … caprolactam imports imports to to North America North America in 2013 in 2013- -2017 2017 The imports of caprolactam in the last few years by exporting countries were mainly dominated by … countries. This is due to a number of factors. First of all, most of the North American countries are part of the … and the import-export operations are much faster, easier and without much documentation... In 2017, in physical terms, the main share of imports belonged to ….It was then followed by … with … tons (…%) and … with … tons (…%). Thefourth and fifth place, respectively, were taken by … and … with ... (…%) and … tons(…%). In value terms, the three leading countries were - …, … and … with importedproducts, equal to … (…% of the total), …(…%) and … USD (…%). Table 12 Main countries, exporting caprolactam to North America in 2013-2017, in thousands of USD and in % Import value in 2013, in 000's of USD USD USD Country A … … … Import value in 2014, in 000's of Import value in 2015, in 000's of Import value in 2016, in 000's of USD … Import value in 2017, in 000's of USD … Share in 2017, in % CAGR 2013- 2017 Exporting country …% …% Country B … … … … … …% …% Country C … … … … … …% …% Country D … … … … … …% …% Country E … … … … … …% …% Country F … … … … … …% …% Country G … … … … … …% …% Country H … … … … … …% …% Country I … … … … … …% …% … … … … … … …% …% Other countries Total … … … … … …% …% … … … … … …% …% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) Page 29of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Structure of the imports of caprolactam to North America in 2017 in value terms, in % Country A X% X% Country B Country C X% Country D X% Country E Country F X% X% Country G Others X% X% Fig. 5 Structure of the imports of caprolactam in North America by importing countries in 2017 in value terms, in %5 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 5Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 30of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 1 12 2. . Characteristics of the consumption of Characteristics of the consumption of caprolactam caprolactam in in North North America America 12.1. 12.1. Volume, value and dynamics of the consumption of Volume, value and dynamics of the consumption of caprolactam 2013 2013- -2017 2017 … caprolactam in in North America North America in in The consumption volume of caprolactam in North America in 2013 was 526 thousand tons, which was valued at … million USD. During the analyzed period, the consumption in both physical and value terms showed mixed dynamics... … Table 13 Volume, value and dynamics of the consumption of caprolactam in North America in 2013-2017, in thousands of tons, thousands of USD and in % Year Market volume, in 000’s tons USD 2013 526 … 2014 … … 2015 … … 2016 … … 2017 … … Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Market value, in 000's of Inventory levels Consumption, in 000’s tons Consumption, in 000's of USD … … … … … …% …% …% …% …% … … … … … (WMStrategy) … Page 31of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Volume and dynamics of the consumption of caprolactam in North America in 2013-2017 250 112% X% X X 110% X 200 108% X X X% X% 106% X% 150 104% 102% 100 100% 100% 98% 50 96% 0 94% 2013 2014 2015 2016 2017 Consumption, in 000's of tons Dynamics, in % Fig. 6 Volume and dynamics of the consumption of caprolactam in North America in 2013-2017, in thousands of tons and in %6 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) … 6Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 32of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 12.2. 12.2. Volume, value and dynamics of the per capita consumption of Volume, value and dynamics of the per capita consumption of caprolactam caprolactam in in North North America America in … in 2013 2013- -2017 2017 The consumption of caprolactam in North America fluctuates a lot among the different countries in both volume and value terms. The North American average consumption in 2013 was … kilograms per capita, which was equal to … USD per capita. In the next five years, the volume of per capita consumption in physical terms ... at CAGR of …% per year to reach … kilograms per capita, while the one in value terms ... at CAGR of …% per annum and reached … USD per person. The highest levels of consumption were recorded in …, … and … in physical and in …, … and … in value terms… … Table 14 Volume and dynamics of the per capita consumption of caprolactam in North America by consuming countries in 2013-2017, in kilograms per capita and in % Consumption per capita in 2013, in kg/capita kg/capita Canada … … Consumption per capita in 2014, in Consumption per capita in 2015, in kg/capita … Consumption per capita in 2016, in kg/capita … Consumption per capita in 2017, in kg/capita … CAGR 2013- 2017 Country …% Mexico … … … … … …% The USA … … … … … …% Average … … … … … …% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) … Page 33of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Deviation of the North American consumption of caprolactam per capita by consuming countries in 2017, in value terms 0.030 0.025 0.020 0.015 0.010 0.005 0.000 Canada Mexico The USA Consumption per capita in 2017, in USD/capita Average North American consumption per capita in 2017, in USD/capita Fig. 7 Deviation of the North American consumption of caprolactam per capita in 2017 by consuming countries in value terms, in USD per capita7 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 7Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 34of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 1 12 2. .4 4. . Balance between supply and demand on the Balance between supply and demand on the caprolactam in in 2013 2013- -2017 2017 and and forecast for its development in the medium term forecast for its development in the medium term … caprolactam market in market in North America North America Due to the high domestic supply, the domestic demand is … to cover it fully, so the local balance between supply and demand in volume terms was … with domestic supply being able to cover …% of the domestic demand in the last five years. In value terms, the situation was very similar, but had different dynamics due to the different per kilogram prices of the caprolactam, produced in North America and the imported ones. In value terms, the balance between domestic supply and domestic demand was …, as the domestic supply was able to cover …%-…% of the domestic demand in the last five years. … Table 15 Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017, in thousands of tons and in % Year Volume of domestic supply, in 000’s tons tons 2013 765 526 2014 … … 2015 … … 2016 … … 2017 … … Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Volume of domestic demand, in 000’s Balance, in 000’s tons Supply, in % to the total demand 145.44% …% …% …% …% 239 … … … … (WMStrategy) Page 35of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Balance between domestic supply and domestic demand on the North American caprolactam market in 2013-2017, in volume terms 400 X X 300 X X X 200 X X X X X 100 0 2013 2014 2015 2016 2017 Volume of domestic supply, in 000's of tons Volume of domestic demand, in 000's of tons Fig. 8 Balance between domestic supply and domestic demand on the caprolactam market in North America in 2013-2017, in thousands of tons8 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 8Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 36of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 1 13 3. Forecast for devel . Forecast for development of the opment of the caprolactam caprolactam market in market in North America North America in in 2018 2018- -2023 2023 13.1. Factors, influencing the development of the 13.1. Factors, influencing the development of the caprolactam the medium term the medium term … caprolactam market in market in North America North America in in In the last five years, the North American caprolactam market was dominated by … and this trend will continue in the medium term. Due to the …, the market will show … in the period until 2023. Understandably, this will happen if the overall North American economy is able to achieve … of …% per year and…. … market development in the medium term under three possible scenarios … 13.2. Forecast for 13.2. Forecast for market development in the medium term under three possible scenarios Under the base scenario for development, the North American economy will show … rates of about …% per year until 2023…. In this scenario, the annual market … rate for the period will be about …% per year, which means that the market volume in 2023 will reach 681 thousand tons or … million USD. Page 37of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Table 16 Volume, value and dynamics of the caprolactam market in North America in 2013-2017 and forecast for its development in 2018-2023 (under the framework of the base scenario), in thousands of tons, thousands of USD and in % Year Market volume, in 000’s tons % 2013 526 …% 2014 … …% 2015 … …% 2016 … …% 2017 … …% 2018F … …% 2019F … …% 2020F … …% 2021F … …% 2022F … …% 2023F 681 …% Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis Dynamics, in Market value, in 000's of USD … … … … … … … … … … … Dynamics, in % …% …% …% …% …% …% …% …% …% …% …% (WMStrategy) Volume and dynamics of the caprolactam market in North America in 2013- 2023F (base scenario) 300 112.00% 110.00% 250 108.00% 200 106.00% 104.00% 150 102.00% 100 100.00% 98.00% 50 96.00% 0 94.00% 2013 2014 2015 2016 2017 2018F 2019F 2020F 2021F 2022F 2023F Market volume, in 000's of tons Dynamics, in % Fig. 9 Volume and dynamics of the caprolactam market in North America in 2013- 2017 and forecast for its development in 2018-2023 (under the framework of the base scenario), in thousands of tons and in %9 Source: Data (Official sources, Expert opinion, WMStrategy calculations), Analysis (WMStrategy) 9Please, bear in mind that the figures, presented in this demo version are for illustrative purposes only and might differ from the real figures you will get by purchasing the full report! Page 38of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Similar reports Similar reports We can provide similar reports with a different geographical coverage. These can be conditionally divided into single-country and regional (multi-country) reports. The main difference between the two is the geographical coverage and research focus. We offer similar reports, covering the following countries/regions: Africa: o Algeria; o Angola; o Botswana; o Cameroon; o Congo (Democratic Republic); o Congo Republic; o Egypt; o Ethiopia; o Equatorial Guinea; o Ghana; o Ivory Coast; o Kenya; o Libya; o Madagascar; o Malawi; o Mauritius; o Morocco; o Mozambique; o Namibia; o Nigeria; o Senegal; o South Africa; o Sudan; o Tanzania; o Togo; o Tunisia; o Uganda; o Zambia; o Zimbabwe; Asia and Pacific: Page 39of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Australia; Bangladesh; Cambodia; India; Indonesia; Malaysia; Myanmar (Burma); Nepal; New Zealand; Pakistan; Philippines; Singapore; Sri Lanka; Thailand; Vietnam; CIS Countries: o Armenia; o Azerbaijan; o Belarus; o Georgia; o Kazakhstan; o Kyrgyzstan; o Moldova; o Russian Federation; o Turkmenistan; o Ukraine; o Uzbekistan; Europe: o Austria; o Belgium; o Bosnia and Herzegovina; o Bulgaria; o Croatia; o Cyprus; o Czech Republic; o Denmark; o Estonia; o Finland; o France; o o o o o o o o o o o o o o o Page 40of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Germany; Greece; Hungary; Iceland; Ireland; Italy; Latvia; Lithuania; Luxembourg; Malta; Montenegro; Norway; The Netherlands; Poland; Portugal; Romania; Serbia; Slovakia; Slovenia; Spain; Sweden; Switzerland; The United Kingdom; Turkey; Middle East: o Bahrain; o Iran; o Iraq; o Israel; o Jordan; o Kuwait; o Lebanon; o Oman; o Qatar; o Saudi Arabia; o Syria; o United Arab Emirates; o Yemen; North America: o o o o o o o o o o o o o o o o o o o o o o o o Page 41of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Canada; Mexico; The USA; o o o North East Asia: o China; o Hong Kong; o Japan; o North Korea; o South Korea; o Taiwan; South and Central America: o Argentina; o Bahamas; o Bolivia; o Brazil; o Chile; o Colombia; o Costa Rica; o Cuba; o Dominican Republic; o Ecuador; o El Salvador; o Guatemala; o Honduras; o Jamaica; o Nicaragua; o Panama; o Paraguay; o Peru; o Trinidad; o Uruguay; o Venezuela; Regional reports for: o Africa; o Europe; o European Union; o Central Europe; o Eastern Europe; o Northern Europe; Page 42of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Southern Europe; Western Europe; Balkan countries; Southeast Europe; Central and Eastern Europe; Baltic countries; Benelux countries; Scandinavian countries; Mediterranean countries; Iberian countries; CIS Countries; Middle East; North America; North East Asia; Asia and Pacific; Asia; South and Central America; OPEC Countries; GCC Countries; BRICS Countries; CIVETS Countries; MINT Countries; Australia and New Zealand; As well as a global report, covering all of the above. o o o o o o o o o o o o o o o o o o o o o o o Feel free to contact us for more information! We offer similar reports, covering the following products/product groups: Acetaldehyde; Acetone; Acrylates; Acrylic Acid; Aniline; Benzene; Bisphenol A; Butanal; Butyl Acetate; Caprolactam; Page 43of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Ethanolamines; Ethylene Oxide; Isopropanol; Low Density Polyethylene (LDPE); Methyl Methacrylate (MMA); Nitrile Butadiene Rubber (NBR); Phenols; Phthalic Anhydride; Polycarbonates; Polymethyl Methacrylate (PMMA); Styrene Butadiene Rubber (SBR); Styrene; Toluene; Vinyl Acetate; Vinyl Chloride; Xylenes; And many more. Feel free to contact us for more information! Page 44of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 About us About us Williams & Marshall Strategy (http://www.wm-strategy.com) is a global full-service market research and consulting company, providing market insight and analysis on a wide range of industries and markets. Our unique research methodology combines quantitative and qualitative analysis and covers the whole value chain of the markets we analyze – from manufacturers and distributors through wholesalers and retailers to the final clients, which allows us to provide unmatched wide and deep industry understanding. Thus, our clients receive actionable insights on the volume, value and dynamics, trends, growth drivers, threats and opportunities of each market – intelligence that helps them be always a step ahead of the competition. WMStrategy’s reports help our clients make informed commercial planning and strategic decisions and so timely tackle the complex challenges and maximize the opportunities that impact their businesses and drive the generation, evaluation and implementation of powerful growth strategies. We are constantly enhancing our research skills and coverage by improving our work and adding new experts and geographical markets to our portfolio, making our products an essential resource for companies at global, national and local level. Our reports free up your resources and offer you timely deep industry understanding and strategic insights, required in today’s increasingly competitive business environment. Page 45of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Our clients Our clients As a global company, we are dealing with a very diverse client base. The companies who trust us come from different geographical regions and from different backgrounds – we have clients, ranging from large, developed economies like the USA, the UK, Germany, France, Italy, Australia, Canada, Japan, etc. to developing countries like Chile, Nigeria, India, Indonesia, Bulgaria, Poland, Russia, etc. Our clients come from different industries – from mining and agriculture through processing and manufacturing to different types of consulting and financial services. They vary from large Fortune 500 companies to small start-up ventures. You can find a sample list of some of our recent clients below10 (provided in no particular order). 10 All logos represent intellectual property of their respective owners. WMS does not have the right to represent any of the above mentioned companies. Page 46of 47 info@wm-strategy.com
Demo version North America: Caprolactam Market. January 2019 Purchase this report Purchase this report You can purchase this report directly at our online store: https://www.wm- strategy.com/catalog/product/view/id/125402/s/north-america-caprolactam- market/ You can inquire about strategy.com/catalog/product/view/id/125402/s/north-america-caprolactam- market/ You can request customization strategy.com/catalog/product/view/id/125402/s/north-america-caprolactam- market/ You can browse other reports in our online store: https://www.wm- strategy.com/store/ You can find out more about us on our website: https://www.wm- strategy.com/ You can contact us with any questions: info@wm-strategy.com this report: https://www.wm- of this report: https://www.wm- Page 47of 47 info@wm-strategy.com